Cumberland Pharmaceuticals (CPIX) Non-Current Deferred Tax Liability (2011)

Cumberland Pharmaceuticals (CPIX) reported Non-Current Deferred Tax Liability of $645029.0 for Q4 2011.

Cumberland Pharmaceuticals (CPIX) Non-Current Deferred Tax Liability (2011) Analysis & Trends

Cumberland Pharmaceuticals (CPIX) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $645029.0 in Q4 2011.

For the quarter ending Q4 2011, Non-Current Deferred Tax Liability changed N/A year-over-year to $645029.0; the trailing twelve-month figure through Dec 2011 stood at $645029.0 (changed N/A YoY), and the FY2011 full-year result was $645029.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability was little changed at $645029.0 in Q4 2011.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $645029.0 in Q4 2011 to a low of $645029.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Cumberland Pharmaceuticals	104.57 Mn	93.23 Mn	7.20 Mn

Download Data

Date	Value
Dec 31, 2011	645,029.00
Dec 31, 2011	645,029.00